Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$33,297,508
+$4,611,665 QoQ
Shares Held
132,322
+0.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#458
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,297,508 | 132,322 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $28,685,843 | 131,895 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $30,070,883 | 131,607 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $30,737,861 | 132,754 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $24,401,419 | 131,459 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $27,414,853 | 130,846 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $23,501,358 | 132,253 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $25,874,224 | 131,022 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $22,430,528 | 130,775 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $23,119,780 | 126,962 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $19,559,228 | 126,213 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $18,497,004 | 124,091 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $16,650,741 | 123,586 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $19,817,022 | 124,346 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $18,884,451 | 116,852 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $15,464,213 | 115,224 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $17,699,629 | 115,563 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $19,812,759 | 122,218 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,818,975 | 138,988 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,301,080 | 132,577 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,652,774 | 130,085 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $12,489,453 | 115,408 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,150,167 | 113,394 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $9,528,127 | 108,781 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,106,035 | 82,563 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,264,875 | 82,227 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||